Article
DirectedCHO: A new miniaturized directed evolution process for phenotype stability trial test of CHO cells before bioreactor scale-up.
SLAS technology - 1 Aug 2024
Thimiri Govinda Raj Deepak B, Musasira N, Takundwa M M
Abstract excerpt
Most of the biopharmaceuticals that are currently on the market are expressed using the Chinese Hamster Ovary (CHO) cell lines. However, the production yield of these biopharmaceuticals is affected due to CHO cellular heterogeneity and challenges in adaptability during the bioreactor scale-up stage. In this communication, we report the protocol for the miniaturized directed evolution process for CHO cells. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
